Home
Scholarly Works
Efficacy and safety of adalimumab (HUMIRA (R)) in...
Conference

Efficacy and safety of adalimumab (HUMIRA (R)) in Canadian clinical practice. A comparison of the Canadian and the European practice: The CanACT and the ReACT trial

Authors

Cividino A

Volume

32

Pagination

pp. 1401-1401

Publisher

J RHEUMATOL PUBL CO

Publication Date

July 1, 2005

Name of conference

12th Winter Workshop of the Canadian-Rheumatology-Association

Conference place

Mt Tremblant, CANADA

Conference start date

March 2, 2005

Conference end date

March 5, 2005

Conference proceedings

JOURNAL OF RHEUMATOLOGY

Issue

7

ISSN

0315-162X

Labels

Contact the Experts team